阿凱迪亞生物科學 RKDA 深 滬
已收盤 11-06 16:00:00 美东时间
0.161
-0.006
-3.54%
華盛通- 最 高0.1668
- 今 開0.1587
- 成交量 17.33万股
- 最 低 0.156
- 昨 收 0.1669
- 總市值 38.79万
- 52周最高 3.87
- 市盈率 靜 --
- 換手率 7.19%
- 52周最低 0.111
- 委 比 66.67%
- 總股本 240.92万
- 歷史最高 7040.00
- 量 比 0.52
- 振 幅 6.47%
- 歷史最低 0.111
- 每 手 1
- 風險率 1.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
Shares of GlucoTrack Inc (NASDAQ:GCTK) rose sharply in pre-market trading following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external, fee-for-service partnership. Innovate GBM, a nonprofit dedicated to glioblastoma research, engaged two of Lokahi’s ai PIPELINE pro...
09-24 17:05
Arcadia Biosciences Shareholders Approve Governance and Capital Moves
An update from Arcadia Biosciences ( ($RKDA) ) is now available. At Arcadia Bio...
09-16 03:27
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Gainers Mangoceuticals (NASDAQ:MGRX) shares increased by 40.0% to $0.75 during Thursday's after-market session. The company's market cap stands at $9.1 million. Laird Superfood (AMEX:LSF) shares moved upwards by 11.88% to $4.9. The company's market cap stands at $46.7 million. As per the press relea...
08-14 05:06
Arcadia Biosciences shares are trading higher after the company reported a year-over-year increase in its Q2 EPS results.
Arcadia Biosciences shares are trading higher after the company reported a year-over-year increase in its Q2 EPS results.
08-14 04:29
Arcadia Biosciences Q2 EPS $(2.09) Up From $(3.26) YoY, Sales $1.443M Down From $1.455M YoY
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.09) per share. This is a 35.89 percent increase over losses of $(3.26) per share from the same period last year. The company reported $1.443 million in sales this quarter. This is a 0.82 percent decrease over sales of $1.455 million ...
08-14 04:25
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Arcadia Biosciences reported second-quarter 2026 results, noting $319K in operating cash use and ending the quarter with $4.2M in cash. Zola sales reached $740K in July, exceeding $1M by early August. The company completed a $4M private placement and plans to launch a new 1-liter espresso in Q4 2026 with pre-launch commitments from major customers, along with three additional products in early 2027.
08-13 20:05
Arcadia Biosciences Grants CEO Bonus, Sets 2026 Meeting
Arcadia Biosciences ( ($RKDA) ) has shared an update. On July 1, 2026, Arcadia ...
07-03 04:50
Arcadia Biosciences Files Prospectus Pursuant To Which Selling Stockholders May Offer Up To 11.92M Shares Of Common Stock For Resale
https://www.sec.gov/Archives/edgar/data/1469443/000119312526285578/rkda-20260626.htm
06-27 04:39
Arcadia Biosciences dips 8% on $4M private placement
Arcadia Biosciences (RKDA) entered into securities purchase agreements for a private placement consisting of ~3.88M shares of common stock, along with Series A-1 and Series A-2 preferred investment op...
06-12 17:57
